Clinical factors associated with advanced colorectal neoplasia in average risk, asymptomatic individuals.

A Andrew J Piscitello (Freenome Inc, South San Francisco, CA) C Chung-Kai Sun (Freenome Holdings, Inc., South San Francisco, CA) A Amanda Culley (Freenome, South San Francisco, CA) K Kristen R. Petersen (Freenome Holdings Inc., South San Francisco, CA) K Karolina Kutnik (Freenome Holdings, Inc., South San Francisco, CA) Z Zhen Meng (Department of Chemistry) R Reinier G.S. Meester (Freenome Holdings, Inc., South San Francisco, CA) C Carole Macaron (Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH) C Carol A. Burke (Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH)

Abstract

e15679 Background: Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the U.S. Advanced precancerous lesions (APL) are at heightened risk of becoming CRC, and along with CRC, comprise the group of lesions called advanced colorectal neoplasia (ACN). Factors associated with ACN for screen-eligible persons remain imperfectly understood due to analyses based on retrospective cohorts, limited sample size, and inclusion of high risk individuals. This analysis quantifies the association between clinical risk factors and ACN in PREEMPT CRC, a large, prospective, multicenter clinical study designed to validate a blood test for early detection of CRC. Methods: Detailed clinical information was collected for over 27,000 average-risk 45- to 85-year-olds (9.6% had ACN) with disease status determined by colonoscopy and histopathology. Clinical factors considered for analysis were based on literature. Best-subset selection of variables was performed based on minimizing AIC to select a final multivariate model. Both unadjusted (i.e. univariate) and adjusted (multivariate) odds ratios (ORs) were reported. Results: The direction and magnitude were generally consistent for univariate vs. multivariate ORs (Table). Older age, male sex, Non-Hispanic ethnicity, higher BMI, tobacco / alcohol use, and hypertension were associated with increased risk of ACN (OR range of 1.01 [95%CI, 1.01-1.02] per age-year to 1.70 [1.47-1.97] for current smokers), whereas other Non-White races were at lower risk vs. Whites (ORs of 0.63 [0.51-0.78] to 0.91 [0.35-1.98]). Conclusions: In PREEMPT CRC, ACN risk is associated with clinical factors, including modifiable risk factors such as smoking and alcohol use, highlighting the importance of behavioral intervention and other risk mitigation strategies. Clinical trial information: NCT04369053 . Factor Univariate OR (95% CI) Multivariate OR(95% CI) Factor Univariate OR(95% CI) Multivariate OR(95% CI) Age 1.01 (1.01-1.02) 1.01 (1.01-1.02) BMI 1.03(1.02-1.04) 1.03(1.02-1.04) Sex: M v F 1.60(1.48-1.73) 1.49 (1.35-1.64) Tobacco Use: Current v NeverFormer v Never 1.73(1.53-1.96)1.37(1.24-1.51) 1.70(1.47-1.97)1.12(0.99-1.26) Race: American Indian or Alaska Native v White 1.08(0.50-2.05) 0.91(0.35-1.98) Alcohol Use: Current v NeverFormer v Never 1.22(1.12-1.33)1.51(1.29-1.76) 1.11(1.00-1.24)1.33(1.09-1.60) Asian v White 0.56(0.47-0.66) 0.63(0.51-0.78) Diabetes: Y v N 1.31(1.12-1.53) 1.15(0.98-1.35) Black or African American v White 0.78(0.68-0.89) 0.70(0.60-0.82) Chronic Kidney Disease: Y v N 2.01(1.29-3.03) 1.49(0.94-2.27) Native Hawaiian or Other Pacific Islander v White 1.38(0.69-2.51) 1.60(0.73-3.13) Hypertension: Y v N 1.33(1.21-1.47) 1.16(1.05-1.29) Other v White 0.76(0.63-0.90) 0.79(0.61-1.01) Ethnicity: Not Hispanic or Latino v Hispanic or Latino 1.48(1.29-1.70) 1.57(1.31-1.89) Unknown v Hispanic or Latino 1.45(1.17-1.80) 1.67(1.26-2.21)

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

A

Andrew J Piscitello

Freenome Inc, South San Francisco, CA

C

Chung-Kai Sun

Freenome Holdings, Inc., South San Francisco, CA

A

Amanda Culley

Freenome, South San Francisco, CA

K

Kristen R. Petersen

Freenome Holdings Inc., South San Francisco, CA

K

Karolina Kutnik

Freenome Holdings, Inc., South San Francisco, CA

Z

Zhen Meng

Department of Chemistry

R

Reinier G.S. Meester

Freenome Holdings, Inc., South San Francisco, CA

C

Carole Macaron

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH

C

Carol A. Burke

Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH